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Abstract The hypoxia-inducible factor-1K (HIF-1K) is an
important transcription factor for cellular responses to oxygen
tension. It is rapidly degraded under normoxic conditions by the
ubiquitin-dependent proteasome pathway. Here we report a
critical role of the 20S proteasome subunit PSMA7 in HIF-1K
regulation. PSMA7 was found to interact specifically with two
subdomains of HIF-1K. PSMA7 inhibited the transactivation
function of HIF-1K under both normoxic and hypoxia-mimicking
conditions. In addition, we show that the PSMA7-mediated
regulation of HIF-1K activity is associated with the proteasome
pathway. ß 2001 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
Oxygen tension is an important factor for the regulation of
mammalian genes that are involved in angiogenesis, vasculo-
genesis, glucose metabolism, and apoptosis [1]. The induction
of these oxygen-sensitive genes by low oxygen tension (hyp-
oxia) is mainly mediated through hypoxia-inducible factor-1
(HIF-1), a basic helix^loop^helix transcription factor [2,3].
HIF-1 is a dimeric transcription factor that is composed of
HIF-1K and HIF-1L, and binds to a consensus sequence (5P-
RCGTG-3P) [4]. Under hypoxic conditions, it up-regulates
messenger RNAs encoding vascular endothelial growth factor
(VEGF), erythropoietin, and glycolytic enzymes. This stimu-
latory e¡ect is due to the stabilization of oxygen-sensitive
HIF-1K. At normoxia, HIF-1K is rapidly degraded, while
HIF-1L is stably expressed regardless of oxygen tension
[5,6]. HIF-1K has two transactivation domains localized to
amino acid residues 531^575 and 786^826. In addition, amino
acid sequences between the two domains were found to inhibit
transactivation function, and thus this region is referred to as
an inhibitory domain [7].
Recent studies have shown that HIF-1K is targeted by the
von Hippel^Lindau (VHL) tumor suppressor protein for poly-
ubiquitination [8]. The VHL protein forms a complex with
elongins B and C, and cullin-2 through the elongin C binding
domain [9,10], and acts as the recognition component of an
E3 ubiquitin ligase complex for poly-ubiquitination [10,11].
The poly-ubiquitinated HIF-1K protein is degraded by the
ubiquitin-dependent 26S proteasomes [12,13]. The 26S protea-
some complex is a ubiquitous multicatalytic protease complex
composed of two large complexes: the 20S catalytic core com-
plex and the 19S regulatory complex [14]. The 19S complex is
required for the recognition of poly-ubiquitinated protein sub-
strates that are degraded inside of the 20S core complex. The
barrel-shaped 20S particle is made up of four rings, each of
which contains seven di¡erent subunits. The two inner rings
contain L-type subunits and the outer rings comprise K-type
subunits. The proteasome is involved in many di¡erent cellu-
lar processes, ranging from the cell cycle process to antigen
processing [15]. In general, the half-lives of the short-lived
protein targets of the proteasome complex span from 30
min to several hours. In contrast, the half-life of HIF-1K
was reported to be less than 5 min under normoxic conditions
[6]. It is still not clear how HIF-1K is degraded so quickly, as
compared to other substrates of the ubiquitin-dependent 26S
proteasome complex.
Here we show that PSMA7, an K-type subunit of the 20S
proteasome core complex, physically interacts with HIF-1K
and inhibits the transactivation activity of HIF-1K by causing
the proteasome-dependent degradation of HIF-1K.
2. Materials and methods
2.1. Cell culture
293T and BOSC 23 [16] cells were routinely maintained in Dulbec-
co’s modi¢ed Eagle’s medium (DMEM) with 0.375% sodium bicar-
bonate, 100 U/ml penicillin, 100 Wg/ml streptomycin, and 10% fetal
bovine serum (FBS) in a 5% CO2 incubator at 37‡C.
2.2. Plasmid constructions
A series of glutathione-S-transferase (GST) fused HIF-1K deletion
mutant plasmids (pEBG/HIF-1K) for expression in mammalian cells
was constructed by polymerase chain reaction, followed by cloning
into the pEBG plasmid. All deletion mutants were con¢rmed by DNA
sequencing analysis. The N-terminal hemagglutinin (HA)-tagged HIF-
1K expression plasmids were constructed by transferring the HIF-1K
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deletion mutants from pEBG/HIF-1K plasmids into the pcDNA3/HA
plasmid. The luciferase reporter plasmid (pFR-Luc) containing the
promoter with ¢ve tandem repeats of GAL4 binding sites was pur-
chased from Stratagene. The full-length HIF-1K cDNA was inserted
into BamHI and XbaI sites of pFA-CMV containing the GAL4 DNA
binding domain to construct pFA-CMV-HIF-1K. pFLAG/PSMA7
was made by inserting the full-length PSMA7 cDNA into pFLAG-
CMV2.
2.3. In vitro binding assays
GST fusion proteins were expressed in Escherichia coli and were
puri¢ed as described [17]. The GST fusion proteins were immobilized
on glutathione-Sepharose 4B beads (Amersham Pharmacia), and then
were incubated with in vitro-translated [35S]methionine-labeled HIF-
1K for 5 h at 4‡C in Nonidet P-40 lysis bu¡er (0.137 M NaCl, 0.02 M
Tris^HCl pH 7.5, 1 mM EDTA, 10% glycerol, 1% Nonidet P-40,
1 mM PMSF, 1 Wg/ml each of leupeptin, aprotinin, and pepstatin).
The beads were washed ¢ve times with the same bu¡er. The bound
proteins were eluted with SDS^PAGE sample bu¡er and were sepa-
rated by SDS^PAGE, followed by autoradiography.
2.4. In vivo binding assays and immunoblotting
Transfected BOSC 23 cells were treated with 125 WM CoCl2 to
mimic hypoxic conditions. In each set of transfections described in
this report, the total DNA concentrations were equalized with empty
plasmids. Unless noted, all transfected cells were subjected to CoCl2
exposure for 16 h. After 48 h of incubation, the cells were washed
with phosphate-bu¡ered saline bu¡er and were lysed with the Nonidet
P-40 lysis bu¡er for 20 min at 4‡C, followed by centrifugation at
10 000Ug for 10 min. The supernatant was incubated with gluta-
thione-Sepharose 4B beads or an anti-FLAG M2 a⁄nity gel (Sigma)
for at least 5 h at 4‡C with rocking. The beads were washed ¢ve times
in the Nonidet P-40 lysis bu¡er. The bound proteins were eluted with
SDS^PAGE sample bu¡er, separated by SDS^PAGE, and transferred
to a nitrocellulose membrane. Immunoblotting assays were performed
using an anti-FLAG M2 antibody (Sigma), an anti-GST antibody
(Sigma), or an anti-HA antibody (Santa Cruz Biotechnology, Inc.),
followed by an incubation with an appropriate secondary antibody
conjugated to horseradish peroxidase. The protein bands were visual-
ized by the ECL system.
2.5. Luciferase assay
293T cells were grown to 50^80% con£uence in 6 well plates, and
were transfected by lipofectamine (Gibco BRL) with 1 Wg each of
pFR-Luc and pFA-CMV-HIF-1K, and 0.5 Wg of pCMV/L-gal with
or without 1 Wg of pFLAG/PSMA7. Total amounts of DNA were
equalized with empty plasmids. After 5 h of transfection in 1 ml of
serum-free medium, an equal volume of medium containing 10% FBS
was added, and the cells were incubated for an additional 24 h. The
medium was then replaced with DMEM with 2% FBS in the absence
or presence of 125 WM CoCl2 for 24 h before harvesting. The lucif-
erase activity was determined using an assay system (Promega) with a
luminometer. The relative fold induction of luciferase activity was
determined and normalized to L-galactosidase activity. All transfec-
tions were done in duplicate and were repeated at least three times.
3. Results and discussion
3.1. Interaction of HIF-1K with the proteasome complex
subunit PSMA7
In order to clarify the regulation mechanisms of the HIF-1K
inhibitory domain (residues 576^785), we carried out yeast
two hybrid screening with a Hela cDNA library, using the
inhibitory domain as the bait [18]. One of the strongly inter-
acting groups contained several independent clones of the
proteasome subunit PSMA7 [19], all of which included a com-
mon amino acid sequence (residues 163^248) (data not
shown). To further con¢rm the interaction between the
HIF-1K and PSMA7 proteins, we performed in vitro binding
assays with 35S-labeled HIF-1K and GST^PSMA7 (residues
139^248) (Fig. 1A). GST and GST^VHL fusion proteins
were used as negative and positive controls, respectively.
GST fusion proteins were incubated with 35S-labeled HIF-
1K. The bound HIF-1K was eluted and subjected to SDS^
PAGE, followed by autoradiography. HIF-1K was bound to
GST^PSMA7 and GST^VHL but not to GST alone, suggest-
ing that the interaction between HIF-1K and PSMA7 is spe-
ci¢c.
To verify the intracellular interaction between HIF-1K and
PSMA7, we transiently transfected the pEBG/HIF-1K full-
length plasmid into BOSC 23 cells along with pFLAG/
PSMA7. The intracellular interaction was con¢rmed by
GST pull-down assays, followed by immunoblotting (Fig.
1B). While the GST alone did not pull down PSMA7, GST-
fused HIF-1K pulled down PSMA7. We also performed co-
immunoprecipitation assays with transiently expressed
FLAG-PSMA7 and HA-HIF-1K to test if PSMA7 could
bring down HIF-1K in a reciprocal way (Fig. 1C). The
HIF-1K protein was detected in the pulled down PSMA7
complex. Taken together, these results indicate that HIF-1K
interacts with PSMA7 in cells.
3.2. Two domains of HIF-1K are involved in the interaction
with PSMA7
We proceeded to map the domain of HIF-1K required for
the interaction with PSMA7 in vivo. While the N-terminal
region of HIF-1K is necessary for DNA binding and dimeri-
zation with HIF-1L, the C-terminal region has several regu-
Fig. 1. HIF-1K associates with PSMA7 in vitro and in vivo. (A)
The GST fusion proteins were immobilized on glutathione-Sephar-
ose 4B, and were incubated with in vitro-translated [35S]methionine-
labeled HIF-1K for 5 h at 4‡C. The bound proteins were eluted and
were separated by 12% SDS^PAGE, followed by autoradiography.
(B) BOSC 23 cells were co-transfected with 1 Wg of pFLAG/
PSMA7, and either the pEBG or pEBG/HIF-1K plasmid. After 48 h
of transfection, lysates were prepared and were incubated with glu-
tathione-Sepharose 4B beads. Bound proteins were eluted and were
subjected to SDS^PAGE. Immunoblotting was performed with ei-
ther an anti-GST or anti-FLAG M2 antibody. (C) The in vivo
binding of HIF-1K to PSMA7 was con¢rmed by co-immunoprecipi-
tation. BOSC 23 cells were co-transfected with pcDNA3/HA-HIF-
1K, and either pFLAG/PSMA7 or empty pFLAG-CMV2. Trans-
fected cell lysates were prepared and were immunoprecipitated with
an anti-FLAG M2 a⁄nity gel. Immunoblotting analysis was per-
formed using an anti-HA antibody. IP, immunoprecipitation; IB,
immunoblot.
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latory domains, including two transactivation domains, an
oxygen-dependent degradation (ODD) domain, and an inhib-
itory domain (Fig. 2A). Since the C-terminal domains are
involved in regulation, we performed binding assays to iden-
tify and localize the PSMA7 binding domains within the C-
terminal region. We transfected a series of HA-HIF-1K dele-
tion mutants together with pFLAG/PSMA7 into cells. From
the lysates of these cells, PSMA7 was immunoprecipitated
with anti-FLAG M2 beads, and the co-precipitated HIF-1K
was probed by immunoblotting with an anti-HA antibody
(Fig. 2B). PSMA7 co-immunoprecipitated the HIF-1K frag-
ments of residues 576^785 (the inhibitory domain), 530^826,
613^826, and 695^826. The HIF-1K fragment of residues 530^
694, however, failed to interact with PSMA7 (Fig. 2B, lane 2).
These results show that the most critical domain for binding is
within residues 695^785. We then constructed a series of
pEBG/HIF-1K deletion mutants and performed binding as-
says, since the pEBG/HIF-1K constructs produced higher lev-
els of recombinant proteins than the HA-HIF-1K constructs
did (Fig. 2C). Consistent with the results shown in Fig. 2B,
PSMA7 interacted with the whole inhibitory domain (residues
576^785) of HIF-1K. Further deletion analysis showed that
the PSMA7 binding domain is localized within residues 726^
785 of HIF-1K. Interestingly, the ODD domain comprising
residues 401^603 also was found to interact with PSMA7
(Fig. 2C, lane 2). Based on these results, we conclude that
the ODD domain and a portion of the inhibitory domain
form complexes with PSMA7 independently. However, the
separation of the ODD domain into two fragments resulted
in a loss of the interaction with PSMA7 (Fig. 2C, lanes 4 and
5). Previously, the N-terminal transactivation domain (resi-
dues 532^585) [3,6,7] was shown to interact with VHL [20].
However, the fragment of residues 530^612, containing the
VHL binding region, did not bind to PSMA7, suggesting
that VHL and PSMA7 occupy di¡erent regions within the
ODD domain of HIF-1K.
3.3. E¡ect of PSMA7 on the transactivation activity of HIF-1K
We performed luciferase reporter assays to test whether
PSMA7 regulates the transactivation activity of HIF-1K.
Transfected cells were either grown under normoxic condi-
tions or treated with a hypoxia-mimicking reagent (125 WM
CoCl2). As shown in Fig. 3, transfection of GAL4/HIF-1K
with the reporter plasmid resulted in an increase of the lucif-
erase activity under both normoxic and CoCl2-treated condi-
tions. In addition to the global increase of luciferase activity
by HIF-1K, when the cells were treated with CoCl2, the lucif-
erase activity was increased by 3-fold as compared to the
activity under normoxic conditions. In contrast, co-transfec-
tion of pFLAG/PSMA7 decreased the transactivation activity
of HIF-1K in a dose-dependent manner. Interestingly, under
normoxic conditions, the relative reduction ratios of the HIF-
1K activity were very similar to those under the hypoxia-mim-
icking conditions. Therefore, these results suggest that
PSMA7 inhibits the HIF-1K transactivation activity and
that its inhibitory function is not oxygen-dependent.
3.4. PSMA7 destabilizes HIF-1K
PSMA7 is a subunit of the 26S proteasome complex that
degrades poly-ubiquitinated proteins. Since our results pro-
vided evidence that PSMA7 interacts with HIF-1K and inhib-
its the HIF-1K-mediated transactivation of the luciferase gene,
Fig. 2. Search for interaction domains of HIF-1K with PSMA7. (A)
Schematic representation of full-length HIF-1K. DBD, DNA bind-
ing domain; PAS, period-ARNT-similar; TAD, transactivation do-
main; ODD, oxygen-dependent degradation. (B) BOSC 23 cells
were co-transfected with pFLAG/PSMA7 and a series of pcDNA3/
HA-HIF-1K, and were lysed. Co-immunoprecipitation assays were
performed with an anti-FLAG M2 a⁄nity gel, followed by immu-
noblotting with an anti-HA antibody. (C) A series of pEBG/HIF-1K
deletion mutants was transfected with pFLAG/PSMA7 DNA. Bind-
ing assays were done as described in Fig. 1B. The pEBG plasmid
was used for transfection in lane 1.
Fig. 3. PSMA7 inhibits the transactivation function of HIF-1K.
293T cells were transfected by lipofectamine with 1 Wg each of the
reporter plasmid pFR-Luc and GAL4/HIF-1K, and 0.5 Wg of
pCMV/L-gal together with 1 or 2 Wg of the pFLAG/PSMA7 plas-
mid. Cells were treated with 125 WM CoCl2 for 24 h. Luciferase ac-
tivities were normalized to L-galactosidase activities. This is a repre-
sentative of three independent experiments that were done in
duplicate.
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we tested whether PSMA7 destabilizes the HIF-1K protein
through the proteasome-dependent pathway. Cell lysates
were prepared from transfected 293T cells grown under hyp-
oxia-mimicking conditions and were subjected to immuno-
blotting with either an anti-HIF-1K antibody or anti-FLAG
M2 antibody (Fig. 4A). Co-expression of PSMA7 decreased
the HIF-1K protein level, suggesting that PSMA7 destabilizes
HIF-1K.
To further study the e¡ect of PSMA7 on HIF-1K, BOSC 23
cells were transfected with a large amount (2 Wg) of the HIF-
1K expression plasmid. This transfection condition produced a
signi¢cant level of the HIF-1K protein and allowed us to
analyze the HIF-1K expression levels clearly. Co-transfection
of pFLAG/PSMA7 decreased the protein level of HIF-1K
(Fig. 4B, lanes 1 and 3, and lanes 2 and 5). Treatment of
co-transfected cells with MG132, a proteasome inhibitor, re-
stored the HIF-1K protein level to that of cells transfected
with the HIF-1K expression plasmid alone (Fig. 4B, lanes 1
and 4). This observation indicates that PSMA7 mediates the
degradation of HIF-1K through the proteasome-dependent
pathway. In addition, the CoCl2 treatment of the PSMA7-
transfected cells failed to stabilize the HIF-1K protein (Fig.
4B, lanes 3 and 5), suggesting that the PSMA7-mediated deg-
radation of HIF-1K is not oxygen-dependent. These results
coincide with the results of transient transfection assays, as
described above (Fig. 3). The oxygen-independent regulation
by PSMA7 may explain, at least in part, why HIF-1K is de-
graded relatively fast even when the cells were at hypoxia or
under the hypoxia-mimicking conditions [6].
There have been several reports about cellular regulatory
proteins and viral proteins that interact with subunits of the
proteasome complex and participate in the proteasome-depen-
dent regulation [21^25]. Since proteasome subunits can be
exchanged with exogenous subunits in vivo and in vitro
[23,26], the regulatory e¡ect of the exogenous PSMA7 on
HIF-1K may be due to the PSMA7-mediated recruitment of
HIF-1K to the proteasome complex. Human hepatitis B virus
X protein (HBX), another binding target of PSMA7, is also
quickly degraded by the proteasome pathway [27], suggesting
that PSMA7 may have a role in recruiting substrates to the
proteasome complex.
Our ¢nding of the interaction between HIF-1K and PSMA7
may be related to a recent report that HBX stimulates the
transcription of VEGF, a target of HIF-1K, under both
hypoxic and normoxic conditions [28]. Since HBX is known
to interact with PSMA7 and to stimulate AP-1 activity by
inhibiting AP-1 degradation [29,30], the binding of HBX to
PSMA7 may also inhibit the degradation of HIF-1K.
The PSMA7 binding motif in the inhibitory domain of
HIF-1K is closely related to the minimal repression domain
(residues 757^785) [7], suggesting that the previously reported
repressive e¡ect of the inhibitory domain might be related to
the interaction of HIF-1K with PSMA7 and the proteasome-
dependent degradation. However, further analyses must be
performed to test this hypothesis, since (i) multiple inhibitory
sequences are present within the inhibitory domain; and (ii)
the transactivation inhibitory function was more apparent at
normoxia [7].
In conclusion, our results demonstrate that PSMA7 binds
and regulates the HIF-1K activity by the oxygen-independent
proteasome pathway.
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